Publications by authors named "Ahmed Idbaih"

Claim this Profile
R
Real-Life Efficacy and Safety of BRAF Inhibitors in Erdheim-Chester Disease.
Francesco Pegoraro, Francesco Peyronel, Matthias Papo, Riccardo Sutera, Francesco Catamerò, Ahmed Idbaih

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working Group.
Isabelle Mahé, Ygal Benhamou, Asmahane Benmaziane, Laurent Bertoletti, Virginie Bichon, Ahmed Idbaih

Arch Cardiovasc Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevation of hCG in CSF in pinealoblastoma: a pitfall rescued by pathological examination.
François Bouille, Karima Mokhtari, Bertrand Mathon, Jérôme Alexandre Denis, Lucia Nichelli, Ahmed Idbaih

Acta Neuropathol Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin-gemcitabine for refractory high-grade meningiomas: A study from the French national OMEGA consortium.
Mathieu Larroquette, Charlotte Bronnimann, Morgan Ollivier, Thomas Daubon, Paul Lesueur, Ahmed Idbaih

Int J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by systems pharmacology and machine learning.
Sergio Corridore, Maïté Verreault, Hugo Martin, Thibault Delobel, Cécile Carrère, Ahmed Idbaih

Br J Pharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease.
Michelangelo Tesi, Francesco Pegoraro, Francesco Peyronel, Jean-François Emile, Francesco Catamerò, Ahmed Idbaih

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients.
Ivan Caramanna, Martin Klein, Martin van den Bent, Ahmed Idbaih, Martin J B Taphoorn

Qual Life Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and therapeutic impact of stereotactic biopsy in very elderly patients with brain tumors.
Louise Deboeuf, Maximilien Riche, Henri Malaizé, Pauline Marijon, Karima Mokhtari, Ahmed Idbaih

J Neurosurg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis.
Chooyoung Baek, Lucas Rincon de la Rosa, Ilyes Aliouat, Loup Guichard, Eva Pappa, Ahmed Idbaih

Eur J Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manganese overload as a co-factor of neurological symptoms in a patient with sclerosing cholangitis due to Langerhans cell histiocytosis.
Jerome Razanamahery, Ahmed Idbaih, Matthias Papo, Fabien Robelin, Jean-Francois Emile

Haematologica· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.
Camille Bigenwald, Damien Roos-Weil, Arnaud Pagès, Zofia Hélias-Rodzewicz, Christiane Copie-Bergman, Ahmed Idbaih

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of clonal inflammatory microglia in histiocytosis-associated neurodegeneration.
Rocio Vicario, Stamatina Fragkogianni, Maria Pokrovskii, Carina Meyer, Estibaliz Lopez-Rodrigo, Ahmed Idbaih

Neuron· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study.
Linda Dirven, Abigirl Machingura, Martin J van den Bent, Corneel Coens, Andrew Bottomley, Ahmed Idbaih

Neurooncol Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocytic meningitis complicating histiocytosis and response to MEK-inhibitor: a case series.
Tom Abrassart, Ahmed Idbaih, Damien Roos-Weil, Damien Galanaud, Fleur Cohen-Aubart

Ann Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA network study.
Alexandre Bertucci, Ondine Dufour, Romain Appay, Vincent Harlay, François Ducray, Ahmed Idbaih

Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort.
Domique Figarella-Branger, Carole Colin, Karima Mokhtari, Emmanuelle Uro-Coste, Ahmed Idbaih

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α-synuclein expression in glioblastoma restores tumor suppressor function and rescues temozolomide drug resistance.
Eric Duplan, Aurore Bernardin, Thomas Goiran, Nathalie Leroudier, Mathew Casimiro, Ahmed Idbaih

Cell Death Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinamide metabolism reprogramming drives reversible senescence of glioblastoma cells.
Ashwin Narayanan, Mirca S Saurty-Seerunghen, Jessica Michieletto, Virgile Delaunay, Arnaud Bruneel, Ahmed Idbaih

Cell Mol Life Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1.
Martin J van den Bent, Enrico Franceschi, Mehdi Touat, Pim J French, Ahmed Idbaih

Neuro Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Examination Skills in Neuromuscular Disorders Through an Educational Video.
Rocio Nur Villar-Quiles, Jebrane Bouaoud, Jean Philippe Foy, Anthony Behin, Marion Masingue, Ahmed Idbaih

Clin Teach· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.
Alice Talpin, Ana Maia, Jean-Marie Carpier, Guillaume Kulakowski, Lucie Aubergeon, Ahmed Idbaih

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, Olivier Chinot, Catherine Carpentier, Ahmed Idbaih

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].
Eugenia Cella, Alberto Bosio, Pasquale Persico, Mario Caccese, Marta Padovan, Ahmed Idbaih

Cancer Treat Rev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives.
Eugenia Cella, Alberto Bosio, Pasquale Persico, Mario Caccese, Marta Padovan, Ahmed Idbaih

Cancer Treat Rev· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Applications of Antisense Oligonucleotides in Cancer: A Focus on Glioblastoma.
Alexandre Khuu, Maïté Verreault, Philippe Colin, Helene Tran, Ahmed Idbaih

Cells· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis